ATS Medical to sell Regeneration Tech cardiovascular tissue processing:
This article was originally published in Clinica
Executive Summary
Minneapolis, Minnesota-based cardiac surgery products maker ATS Medical is to promote, market and solicit orders for Regeneration Technologies' processed cardiovascular allograft tissue under an exclusive deal effective from July 21. Alachua, Florida-based Regeneration Technologies' cardiovascular subsidiary, formerly known as Alabama Tissue Center, processes heart valves, veins, arteries, patches and other cardiovascular tissue for reconstructing congenital abnormalities in children and repairing adults' heart valves. The US market for cardiovascular allograft tissue is worth around $40m.